Applied DNA Sciences, Inc.
APDN
$4.83
$0.3156.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 983.40K | 1.20M | 813.10K | 797.50K | 929.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 983.40K | 1.20M | 813.10K | 797.50K | 929.60K |
| Cost of Revenue | 612.50K | 512.50K | 568.20K | 552.30K | 634.00K |
| Gross Profit | 370.80K | 684.10K | 244.90K | 245.20K | 295.70K |
| SG&A Expenses | 2.98M | 2.63M | 2.68M | 2.68M | 3.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.45M | 4.16M | 4.08M | 4.14M | 4.55M |
| Operating Income | -3.46M | -2.96M | -3.27M | -3.35M | -3.62M |
| Income Before Tax | -3.34M | -2.67M | -3.31M | 1.85M | -4.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.34M | -2.67M | -3.31M | 1.85M | -4.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 31.90K | 29.30K | 17.00K | 30.30K | 23.30K |
| Net Income | -3.30M | -2.64M | -3.30M | 1.88M | -4.47M |
| EBIT | -3.46M | -2.96M | -3.27M | -3.35M | -3.62M |
| EBITDA | -3.34M | -2.91M | -3.19M | -3.21M | -3.43M |
| EPS Basic | -230.31 | -417.53 | -240.01 | -- | -- |
| Normalized Basic EPS | -17.37 | -38.99 | -149.54 | -- | -- |
| EPS Diluted | -230.31 | -417.53 | -240.01 | -- | -- |
| Normalized Diluted EPS | -17.37 | -38.99 | -149.54 | -- | -- |
| Average Basic Shares Outstanding | 118.20K | 42.00K | 13.70K | -- | -- |
| Average Diluted Shares Outstanding | 118.20K | 42.00K | 13.70K | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |